Lai; Zhong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lai; Zhong.The latest application filed is for "cyclobutyl pyrazolopyrimidine pde9 inhibitors".

Company Profile

4.13.15

Lai; Zhong - East Brunswick NJ
Lai; Zhong - Kenilworth NJ US
Lai; Zhong - Scotch Plains NJ
Lai; Zhong - Rahway NJ US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Cyclobutyl Pyrazolopyrimidine Pde9 Inhibitors App 20220017525 - Arasappan; Ashok ; et al.	2022-01-20
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors Grant 10,934,294 - Arasappan , et al. March 2, 2	2021-03-02
Hydroxy isoxazole compounds useful as GPR120 agonists Grant 10,864,211 - Debenham , et al. December 15, 2	2020-12-15
Pyrazolopyrimidine Pde9 Inhibitors App 20200140445 - ARASAPPAN; Ashok ; et al.	2020-05-07
Hydroxy Isoxazole Compounds Useful As Gpr120 Agonists App 20190269679 - Debenham; John S. ; et al.	2019-09-05
Pyrazolopyrimidine Pde9 Inhibitors App 20180354955 - ARASAPPAN; Ashok ; et al.	2018-12-13
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C Grant 9,549,921 - He , et al. January 24, 2	2017-01-24
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases Grant 9,549,917 - McComas , et al. January 24, 2	2017-01-24
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C Grant 9,493,461 - Dai , et al. November 15, 2	2016-11-15
Heterocyclic Compounds And Methods Of Use Thereof For The Treatment Of Hepatitis C App 20160143895 - He; Shuwen ; et al.	2016-05-26
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases Grant 9,265,773 - McComas , et al. February 23, 2	2016-02-23
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C Grant 9,242,998 - He , et al. January 26, 2	2016-01-26
Tetracyclic Heterocycle Compounds And Methods Of Use Thereof For The Treatment Of Hepatitis C App 20150368265 - He; Shuwen ; et al.	2015-12-24
Tetracyclic Heterocycle Compounds And Methods Of Use Thereof For The Treatment Of Hepatitis C App 20150368246 - Dai; Xing ; et al.	2015-12-24
Tetracyclic Heterocycle Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20140213571 - Liverton; Nigel J. ; et al.	2014-07-31
Heterocyclic-substituted Benzofuran Derivatives And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20140199263 - McComas; Casey Cameron ; et al.	2014-07-17
Oxadiazole beta carboline derivatives as antidiabetic compounds Grant 8,754,099 - Guo , et al. June 17, 2	2014-06-17
Imidazole Derivatives App 20140088124 - DeVita; Robert J. ; et al.	2014-03-27
Oxadiazole Beta Carboline Derivatives As Antidiabetic Compounds App 20120264777 - Guo; Liangqin ; et al.	2012-10-18
Oxadiazole Beta Carboline Derivatives As Antidiabetic Compounds App 20100184799 - DU; WU ; et al.	2010-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.